Contraceptives, Oral
Esthetics
Genetic Predisposition to Disease
Melanosis

Melasma

Melasma is a common acquired disorder of hyperpigmentation that presents persistent diagnostic and therapeutic challenges in dermatologic practice. The condition predominantly affects sun-exposed facial areas and appears as symmetric brown-to-gray macules and patches. Pathogenesis is multifactorial, involving ultraviolet and visible light exposure, hormonal influences, genetic susceptibility, and contributions from the vasculature and dermis. Risk factors include female sex, pregnancy, oral contraceptive use, and positive family history. Melasma typically follows a chronic, relapsing course and may be associated with significant psychosocial distress. Diagnosis relies on clinical distribution, Wood lamp examination, and selective histopathologic evaluation to support classification and prognosis. Management emphasizes long-term control through photoprotection, patient education, and individualized treatment strategies rather than relying solely on short-term pigment clearance. Recurrence and treatment-related adverse effects remain common challenges. This educational activity enhances clinician competence in the comprehensive evaluation and management of melasma. Participants deepen their understanding of etiology, risk factors, pathogenesis, and clinical presentation while strengthening their skills in diagnostic assessment and in selecting evidence-based topical, oral, and procedural therapies. Instruction highlights individualized treatment planning, prevention of recurrence, and mitigation of adverse effects through sustained photoprotection and patient counseling. Collaboration with an interprofessional healthcare team, including dermatology nurses, pharmacists, and aesthetic specialists, supports coordinated care, improves therapy adherence, and promotes durable clinical outcomes for individuals with melasma.

Credit & MOC Details

Credit information is provided by the course provider. We recommend confirming credit eligibility with the provider or your licensing board before starting the activity.